CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Immunobiotics, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Immunobiotics, Inc.
101 North Citrus
Suite 4C
Phone: (800) 524-9172p:800 524-9172 Covina, CA  91723  United States

On 9/9/2014, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of Immunobiotics, Inc. for failure to make required periodic filings with the Commission
This company is no longer actively traded on any major stock exchange.

Business Summary
Immunobiotics, Inc. is a development-stage company engaged in the business of licensing the manufacture, distribution and sale of nutraceutical products that are made of naturally occurring dietary substances. The Company has two product lines: the LutiMax product line and the LutiSport product line, both of which are manufactured and sold by SYNORx, Inc. under a license granted from the Company. In addition, both product lines include products for human consumption and products for consumption by household pets. The LutiMax line of products includes LutiMax 10 milligrams tablets, LutiMax 100 milligrams Lozenges and LutiSyn Capsules for human consumption and a powder for canine consumption. LutiMax is a dietary supplement, the two ingredients of which are two bioflavonoids, Luteolin and Rutin.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201012/31/2009YesYes---

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer Thomas P.Lahey 54 4/23/2010 7/20/2007
Chief Financial Officer, Vice President, Treasurer, Secretary, Director Vithal J.Rajadhyaksha 71 7/20/2007 7/20/2007

Business Names
Business Name
ImmunoBiotics Inc
Immunobiotics, Inc.

General Information
Stock Exchange: OTC
Federal Tax Id: 200947115


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023